The legionellosis.
Following the discovery of Legionella pneumophila as the cause of an epidemic of pneumonia at an American Legion Convention in Philadelphia, a group of related bacteria were recognized as additional human pathogens. This newly established bacteria genus, Legionella, includes the agents of Legionnaires' Disease, Pittsburgh pneumonia and several related infections. A number of researches have been performed in the past few years about these bacteria; many of these data are here summarized to give an idea of the most important characteristics of Legionella and of the diseases they cause.
D000917:Antibody Formation; D001424:Bacterial Infections / Q000503:physiopathology*; D004196:Disease Outbreaks; D004917:Erythromycin / Q000627:therapeutic use; D006801:Humans; D007875:Legionella / Q000145:classification / Q000472:pathogenicity; D007877:Legionnaires' Disease / Q000188:drug therapy / Q000453:epidemiology / Q000276:immunology; D010641:Phenotype; D011014:Pneumonia / Q000188:drug therapy / Q000382:microbiology; D011183:Postoperative Complications / Q000382:microbiology; D012293:Rifampin / Q000627:therapeutic use; D012703:Serotyping; D013752:Tetracycline / Q000627:therapeutic use
D004917:Erythromycin; D013752:Tetracycline; D012293:Rifampin